Adeptrix, founded in Beverly, United States, is dedicated to advancing bio-analytical applications through its proprietary Bead Assisted Mass Spectrometry (BAMS) technology. The company's core mission is to provide rapid, precise, and sensitive detection of target analytes. Adeptrix offers a range of analytical reagents and assays, particularly focusing on multiplexed and high-throughput applications in proteomics. Their products are designed to enhance translational research by enabling detailed monitoring of key proteins and cellular signaling pathways.
Notable figures associated with Adeptrix include experts in mass spectrometry and bio-analytical sciences, though specific names are not provided. The company has achieved significant milestones in developing its BAMS platform, which has been recognized for its innovative approach to immunoassays measured by MALDI mass spectrometry. Adeptrix's impact is evident in its contribution to more efficient and accurate proteomic research, facilitating advancements in biological and medical research.
